Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Starling Oncology, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 11 | 1 | 12 | +2 |
| Shares | 3.81M | 6.13K | 3.99M | +184.9K (+4.9%) |
| Value | $195.4K | $314 | $469.0K | +$273.9K (+140.4%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (3)
Institutions that held Starling Oncology, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FreeGulliver LLC | 76,993 | $9.24K | 0.00% |
| Clear Street Group Inc. | 6,128 | $735 | 0.00% |
| Oasis Management Co Ltd. | 100,000 | – | – |
Sold out (1)
Institutions that held Starling Oncology, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| UBS Group AG | 3,670 | $187 |
Not filed for Q3 2025 yet (1)
Institutions that held Starling Oncology, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Clear Street LLC | 6,128 | $314 |